Gallic acid potentiates the anticancer efficacy of cisplatin in ovarian cancer cells through modulation of the PI3K/AKT/mTOR and CXCL12/CXCR4 signaling pathways
This study provides scientific evidence for the potential use of GA as an adjuvant drug in ovarian cancer treatment.
Authors
- Liang Hong (ORCID: https://orcid.org/0000-0003-1101-7046)
- Yong Tang (ORCID: https://orcid.org/0000-0001-9214-4412)
- Qi Wang (ORCID: https://orcid.org/0000-0001-9260-9099)
- Zhijun Song (ORCID: https://orcid.org/0000-0002-0198-7447)
- Tao Shan (ORCID: https://orcid.org/0000-0001-6680-9302)
- Tingting Lu (ORCID: https://orcid.org/0000-0001-6998-5969)
- Wenjie Wang
- Jinlan Liang
Institutions
- Guangxi University (CN)
- Guangxi Medical University (CN)
- Guangxi Medicinal Botanical Garden (CN)
- Tumor Hospital of Guangxi Medical University (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-09-22
- DOI
- https://doi.org/10.3389/fonc.2025.1653538
- Citations
- 1
- Primary Topic
- Chemokine receptors and signaling
- Type
- article
- Field-Weighted Citation Impact
- 1.05